Biotech
Attract investment & partnerships
We surveyed marketing professionals across the life sciences industry—from biotech to pharma—to explore how AI is transforming their strategies. The findings highlight adoption trends, common tools, pain points, and future priorities.
Citation Policy: Please feel free to use these statistics in any commercial or non-commercial capacity. If you use the statistics we require a link to NANOBOT
Does your company currently use AI in marketing?
67% of lifescience companies already use AI in marketing
How long have you been using AI in marketing?
55%: have been using it for 1–2 years
35%: for less than a year
10%: for over 3 years
AI is still new for many, but momentum is clearly building.
CRM adoption is balanced: 25% each use Salesforce, HubSpot, others, or no CRM at all
Does your CRM system have AI-powered features integrated?
40% of CRM systems include AI functionality
60% are either considering AI, don’t plan to add it, or aren’t sure
🧩 AI integration into marketing infrastructure is still emerging.
75% say AI is an important part of their Marketing
Which AI-powered tools do you currently use for marketing?
60%: Chatbots
40%: AI-generated content
30%: Predictive analytics
20%: Personalization
10%: Email automation
Which AI platforms do you use most?
95%: OpenAI (ChatGPT, DALL·E, Whisper)
40%: Microsoft Copilot
15% each: Anthropic Claude and Google Gemini
👑 OpenAI is the dominant AI platform for Lifescience marketers today.
Which AI-powered content creation platforms do you use?
35% not using AI-powered content platforms
65% not using AI workflow automation
65% not using AI agent platforms
💡 Plenty of room to grow in automation adoption.
How has AI impacted your marketing?
85%: Content creation
60%: Market research
55%: Personalization
50%: Lead generation
Please select all the purposes for which you have used AI tools this year?
50%: Report marketing cost savings
20%: Increased lead gen
10–15%: Improved engagement with HCPs, patients, or conversions
30%: No noticeable impact yet
📉 While results vary, cost reduction is the standout benefit.
70% of Lifescience Marketers automate up to 25% of marketing using AI
25% of Marketers automate up to 50% of their Marketing
Only 5% automate more than 75% of their marketing activities
🚨 Most are still in the early phases of automation.
Which AI-generated content types do you use?
80%: Social media posts
55%: Email campaigns
50%: Blog posts
35%: Videos/images
🧠 Top-of-funnel content dominates AI generation.
How do your customers respond to AI-generated content?
45%: No noticeable difference
30%: More engagement
10%: Less engagement
How will your AI investment change over the next 12 months?
60% plan to increase AI investment
40% plan to maintain current levels
0% plan to reduce spending
Which future AI capabilities interest you the most?
What marketers want next:
63%: AI-driven marketing
57% each: Predictive analytics & content creation
37%: AI-powered sales
📌 Strategic automation and advanced insights are top of mind.
What are the reasons you haven't used AI tools?
Among non-users, top reasons were:
44%: No perceived need
33%: Lack of expertise
33%: Unclear ROI
11%: Regulatory concerns
🕵️ Interestingly, none cited AI being too expensive.
Do you plan to start using AI in the next 12 months?
18% plan to start using AI within 12 months
64% are unsure
8% have no plans yet
The future of AI in life science marketing is clear: early adopters are gaining ground, especially in content and cost-efficiency. However, widespread automation, deeper CRM integration, and advanced use cases like AI-powered sales are still ahead.
Marketers who start preparing now will be ahead of the curve—both strategically and competitively.
NANOBOT is ready to help you to navigate in the ocean of AI apps and integrations. Let`s catch up to discuss recent AI updates!